Review
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Oct 15, 2023; 15(10): 1675-1690
Published online Oct 15, 2023. doi: 10.4251/wjgo.v15.i10.1675
Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives
Rodica Bîrlă, Petre Hoara, Florin Achim, Valeriu Dinca, Diana Ciuc, Silviu Constantinoiu, Adrian Constantin
Rodica Bîrlă, Florin Achim, Silviu Constantinoiu, Adrian Constantin, Department of General Surgery, Carol Davila University, Bucharest 011172, Romania
Petre Hoara, Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest 020021, Romania
Valeriu Dinca, Diana Ciuc, Faculty of Medicine, “Titu Maiorescu” University, Bucharest 031593, Romania
Author contributions: Birla R and Constantin A designed the article framework; Birla R, Constantin A and Hoara P drafted the manuscript; Achim F, Dinca VG, Ciuc D, and Constantinoiu S critically revised the essential intellectual content of the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: There is no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Petre Hoara, MD, PhD, Assistant Lecturer, Department of General Surgery, Carol Davila University of Medicine and Pharmacy, No. 37 Dionisie Lupu str, District 2, Bucharest 020021, Romania. petre.hoara@umfcd.ro
Received: July 5, 2023
Peer-review started: July 5, 2023
First decision: August 15, 2023
Revised: September 4, 2023
Accepted: September 22, 2023
Article in press: September 22, 2023
Published online: October 15, 2023
Processing time: 97 Days and 4.4 Hours
Core Tip

Core Tip: Minimally invasive surgery is increasingly indicated in the management of malignant disease. Although oesophagectomy is a difficult operation, with a long learning curve, there is actually a shift towards the laparoscopic/thoracoscopic/robotic approach, due to the advantages offered to the patient and surgeon. The short- term and long-term results, as well as the benefits for the patient – reduced surgical aggressiveness, quick and easy recovery, offer this type of surgical treatment the premises for future development. This article reviews the updates and perspectives on the minimally invasive approach for gastro-oesophageal junction adenocarcinoma.